The gaps in women’s health today didn’t appear by accident, and they aren’t unique to any one country. For most of the history of modern medicine, research, testing and funding treated men as the default.
The effects are still measurable. In a 2024 global analysis of 183 widely used treatments, based on more than 650 research papers, only half had results reported separately for women and men. The same report estimated that closing the women’s health gap could add at least US$1 trillion a year to the global economy by 2040 (World Economic Forum and McKinsey Health Institute, 2024).
For centuries, women’s symptoms were blamed on the womb. In the twentieth century, a well-meant urge to protect pregnancies helped keep women out of drug trials, and laboratory research defaulted to male animals on the assumption that female hormones would make results messy. Each of those ideas has since been tested, challenged or reversed. This timeline traces how, with Australia’s part in the story alongside the international milestones.
The key figures from this history are also set out in In numbers: Then.
Ancient Greece
“Hysteria”: blaming the womb
Writers in the Hippocratic tradition put a whole range of women’s symptoms down to movement of the uterus. The Greek word for uterus, hysteron, gave the condition its name: hysteria. Similar ideas appear in Egyptian medical writing more than a thousand years earlier. The idea that women’s bodies and minds were governed by their reproductive organs lasted for more than two thousand years.
Source: Women and hysteria in the history of mental health (Tasca C et al.). Clinical Practice and Epidemiology in Mental Health, 8, 2012.
1872
Healthy ovaries are removed to treat "insanity"
Surgeons began removing women’s normal ovaries, a procedure known as Battey’s operation. It became a fashionable treatment for “menstrual madness”, nymphomania, masturbation and “all cases of insanity”, and was backed by leading gynaecologists and psychiatrists. A 2006 review in a medical journal called it one of the great medical scandals of the nineteenth century.
Source: Ovariotomy for menstrual madness and premenstrual syndrome: 19th century history and lessons for current practice (Studd J). Gynecological Endocrinology, 22(8), 2006.
1890
Australia's first registered woman doctor had to train overseas
Constance Stone went overseas to study medicine because the University of Melbourne did not admit women to its medical course. She graduated in Toronto in 1888. When she returned in 1890, she became the first woman to register with the Medical Board of Victoria, and the first woman registered as a doctor in Australia. Her sister Clara was among the first women to enter Melbourne’s medical school, in 1887, and one of the first two to graduate, in 1891.
Source: Dr Constance Stone (Victorian Honour Roll of Women). Victorian Government.
1892
“The Yellow Wallpaper”: a patient writes back
The writer Charlotte Perkins Gilman published a short story, “The Yellow Wallpaper”, based on her own experience of the “rest cure”. This common treatment for depression at the time told patients to stop all work and activity. In the story, as in Gilman’s life, the treatment made things worse, because it ignored what the patient herself needed.
Source: The modern-day “Rest Cure”: “The Yellow Wallpaper” and underrepresentation in clinical research (Villar CF). Philosophy, Ethics, and Humanities in Medicine, 19(1), 2024.
1896
Women doctors start their own hospital in Melbourne
Eleven women doctors, led by Constance Stone, decided to set up a hospital of their own. It began as an outpatients’ dispensary in La Trobe Street, Melbourne, and became the Queen Victoria Hospital for Women and Children, which opened in 1899.
Source: Dr Constance Stone (Victorian Honour Roll of Women). Victorian Government.
1961
The pill arrives: a revolution
In February 1961 the oral contraceptive pill became available in Australia as Anovlar. For the first time, women could reliably decide whether and when to have children. It needed a prescription, many doctors at first prescribed it only to married women, and it carried a 27.5% “luxury tax”. Talk to a doctor before starting, changing or stopping any medication.
Source: The pill: a short history (de Costa C). O&G Magazine, RANZCOG, 22(1), 2020.
1961
Thalidomide
Thalidomide was prescribed to ease morning sickness in early pregnancy. In December 1961, Sydney obstetrician William McBride reported in The Lancet that babies born to women who had taken it were being born with severe malformations, including missing limbs. In Germany, paediatrician Widukind Lenz reached the same conclusion. The drug was withdrawn. The disaster left a deep fear of exposing pregnancies to untested medicines, a fear that shaped the decades that followed.
Source: Thalidomide: an unanticipated adverse effect (Vandenbroucke JP). The James Lind Library, 2003.
1972
The pill becomes affordable
In December 1972 the federal government removed the sales tax on all contraceptives, which then stood at 27.5%, and listed the pill on the Pharmaceutical Benefits Scheme, markedly reducing its cost. Talk to a doctor before starting, changing or stopping any medication.
Source: Australian Social Trends 1998 (4102.0). Australian Bureau of Statistics, 1998.
1977
Women who could become pregnant are kept out of early drug trials
The US Food and Drug Administration recommended that anyone who could become pregnant be excluded from early-phase drug research, to protect a potential fetus. In practice, most women were left out of early clinical trials, so less was learned about how new medicines affected them.
Source: Guideline for the Study and Evaluation of Gender Differences in the Clinical Evaluation of Drugs (July 1993), The Embryo Project Encyclopedia (Meek C). Arizona State University, 2019.
1980
Hysteria leaves the diagnostic manual
The third edition of the US psychiatric diagnostic manual, DSM-III, deleted “hysterical neurosis”. The symptoms once grouped under hysteria were reclassified, mostly as dissociative disorders, ending the formal link between a woman’s uterus and her state of mind.
Source: Women and hysteria in the history of mental health (Tasca C et al.). Clinical Practice and Epidemiology in Mental Health, 8, 2012.
1989
Aspirin is shown to prevent heart attacks, in 22,071 men
The US Physicians’ Health Study tested whether low-dose aspirin could prevent heart disease in 22,071 doctors, all of them men. Aspirin cut their risk of a first heart attack by 44%. The result shaped advice on aspirin for heart health worldwide, even though no women had been studied.
Source: Final report on the aspirin component of the ongoing Physicians' Health Study. New England Journal of Medicine, 321(3), 1989.
1990–93
The US starts requiring women in research
In 1990 the US National Institutes of Health (NIH) created an Office of Research on Women’s Health. In 1993 Congress passed the NIH Revitalization Act, which required women and minorities to be included in NIH-funded clinical research, and called for large late-stage trials to be analysed for differences between women and men.
Source: The integration of sex and gender considerations into biomedical research: lessons from international funding agencies (White J et al.). Journal of Clinical Endocrinology and Metabolism, 106(10), 2021.
1991
Australia starts a national cervical screening program
The National Cervical Screening Program began in 1991. The health department says the number of people developing cervical cancer has fallen significantly since then. In 2017 the Pap test was replaced by the Cervical Screening Test, which looks for HPV (human papillomavirus).
Source: About the National Cervical Screening Program. Australian Government Department of Health, Disability and Ageing.
1993
The 1977 exclusion is reversed
In July 1993 the FDA issued new guidance that lifted the restriction on most women who could become pregnant taking part in early-phase drug trials, and encouraged their participation instead. It ended sixteen years in which most women had been kept out of early trials by default.
Source: Evaluation of Sex Differences in Clinical Investigations (guidance for industry). US Food and Drug Administration, 2025.
1998
A Melbourne surgeon shows the textbooks have the clitoris wrong
Urologist Helen O’Connell and colleagues at the Royal Melbourne Hospital dissected ten female cadavers and found that standard anatomical descriptions were inaccurate. The clitoris is far more extensive than the flat drawing in most textbooks, reaching several centimetres into the body and wrapping around the urethra and vagina. Her later review found that a German anatomist, Georg Ludwig Kobelt, had described it accurately in the nineteenth century. The knowledge had existed, but it had dropped out of the textbooks.
Source: Anatomical relationship between urethra and clitoris (O'Connell HE et al.). Journal of Urology, 159(6), 1998.
2001
Most drugs pulled from the US market were riskier for women
A US government audit looked at the 10 prescription drugs withdrawn from the US market since January 1997. Eight of them posed greater health risks for women than for men. Four of the eight were simply prescribed more often to women, but the other four were widely prescribed to both sexes and still caused more harm in women.
Source: Drug safety: most drugs withdrawn in recent years had greater health risks for women (GAO-01-286R). US General Accounting Office, 2001.
2005
When women are finally tested, aspirin works differently
Sixteen years after the men’s study, the Women’s Health Study reported results from 39,876 women aged 45 and over. Overall, aspirin did not lower women’s risk of a heart attack or of dying from heart disease, although it did lower their risk of stroke. Only women aged 65 and over saw a reduction in heart attacks. Advice built on men had not simply carried over to women.
Source: A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women (Ridker PM et al.). New England Journal of Medicine, 352(13), 2005.
2006
Canada starts asking researchers about sex and gender
The Canadian Institutes of Health Research began building sex- and gender-based analysis into its funding policy and its guidance for applicants and reviewers. From 2010, grant applicants had to report how sex and gender were considered in their study design. This was a prompt to think about sex and gender, not a rule that animal studies must include females.
Source: The integration of sex and gender considerations into biomedical research: lessons from international funding agencies (White J et al.). Journal of Clinical Endocrinology and Metabolism, 106(10), 2021.
2007
Australia begins vaccinating against HPV
Australia’s HPV immunisation program started in 2007, with vaccines given through schools. Vaccination and screening are the basis of Australia’s aim to eliminate cervical cancer as a public health problem by 2035.
Source: National Strategy for the Elimination of Cervical Cancer in Australia. Australian Government Department of Health and Aged Care, 2023.
2011
Most animal research still studies only males
A survey of research on mammals found a male bias in 8 disciplines. It was most extreme in neuroscience, where studies of only male animals outnumbered studies of only female animals by 5.5 to 1.
Source: Sex bias in neuroscience and biomedical research (Beery AK, Zucker I). Neuroscience and Biobehavioral Reviews, 35(3), 2011.
2013
PMDD becomes a full psychiatric diagnosis
Premenstrual dysphoric disorder was included as a full diagnosis in DSM-5, the fifth edition of the US psychiatric diagnostic manual. Severe mood symptoms tied to the menstrual cycle were formally recognised as a mental health condition in their own right.
Source: The prevalence of premenstrual dysphoric disorder: systematic review and meta-analysis (Reilly TJ et al.). Journal of Affective Disorders, 349, 2024.
2013
Women's dose of a common sleeping pill is cut in half
In January 2013, the US Food and Drug Administration told manufacturers to halve the recommended starting dose of zolpidem (sold as Ambien and other brands) for women, from 10 mg to 5 mg. Women clear the drug from their bodies more slowly than men, so more of them were still impaired the next morning, including when driving. Zolpidem had been approved in the US since 1992.
Source: Zolpidem and driving impairment: identifying persons at risk (Farkas RH, Unger EF, Temple R). New England Journal of Medicine, 369(8), 2013.
2014
The "too variable" excuse is tested, and fails
A common reason for leaving female animals out of research was that their hormonal cycles would make results too variable. A review of 293 studies in mice tested this directly. Females tested without tracking their cycle were not more variable than males on any measure, and males were more variable on several.
Source: Female mice liberated for inclusion in neuroscience and biomedical research (Prendergast BJ, Onishi KG, Zucker I). Neuroscience and Biobehavioral Reviews, 40, 2014.
2016
The US requires sex to be considered in animal and human studies
From January 2016, researchers applying for NIH funding had to explain how they would account for sex as a biological variable in studies of vertebrate animals and humans. The NIH pointed to over-reliance on male animals and cells as a reason, warning that it could hide important differences in health and disease.
Source: Consideration of Sex as a Biological Variable in NIH-funded Research (NOT-OD-15-102). US National Institutes of Health, 2015.
2016
A contraceptive injection for men is tested, then stopped
Results were published from a trial of hormone injections for men, co-sponsored by a World Health Organization research programme and CONRAD. It worked for about 96% of continuing users, but recruitment had been stopped early on the advice of an external safety review committee, after side effects including depression and other mood changes. Even so, more than 75% of the men taking part said they would be willing to use it. Talk to a doctor before starting, changing or stopping any medication.
Source: Efficacy and safety of an injectable combination hormonal contraceptive for men (Behre HM et al.). Journal of Clinical Endocrinology and Metabolism, 101(12), 2016.
2017
An apology to women with endometriosis
On 5 December 2017, at an event at Parliament House in Canberra, the federal Health Minister made a public apology to Australians living with endometriosis and committed the government to developing a National Action Plan for Endometriosis.
Source: Endometriosis Coalition. Pelvic Pain Foundation of Australia.
2018
Australia's first National Action Plan for Endometriosis
In July 2018 the federal Department of Health published Australia’s first National Action Plan for Endometriosis, setting priorities across awareness and education, clinical management and care, and research.
Source: National Action Plan for Endometriosis (copy hosted by the Australian Women's Health Alliance). Australian Government Department of Health, 2018.
2018
Australia apologises to women harmed by pelvic mesh
Transvaginal mesh implants were widely used to treat pelvic organ prolapse and incontinence after childbirth. Many women were left with chronic pain and other serious complications. After a Senate inquiry reported in 2018, Health Minister Greg Hunt made a national apology in October 2018 to the women affected, acknowledging their “historic agony and pain”.
Source: Federal Health Minister Greg Hunt issues national apology. newsGP, Royal Australian College of General Practitioners, 2018.
2019
The World Health Organization recognises PMDD
PMDD was included in ICD-11, the World Health Organization’s international classification of diseases, which health systems around the world use to record and count illness.
Source: The prevalence of premenstrual dysphoric disorder: systematic review and meta-analysis (Reilly TJ et al.). Journal of Affective Disorders, 349, 2024.
2024
Australia's research funders ask for sex and gender to be considered
In 2024 the National Health and Medical Research Council (NHMRC) and the federal Department of Health jointly published a statement asking researchers to consider sex, gender, variations of sex characteristics and sexual orientation in health and medical research, including whether studies collect data from both males and females.
Source: Statement on Sex, Gender, Variations of Sex Characteristics and Sexual Orientation in Health and Medical Research. National Health and Medical Research Council and Australian Government Department of Health, 2024.
2026
Considering sex and gender becomes a requirement
The statement was updated in late 2025. From 2026, research funded by the NHMRC and the Medical Research Future Fund (MRFF) must consider sex and gender at all stages, from design to reporting.
Source: Statement on sex and gender in health and medical research. National Health and Medical Research Council, 2026.
2026
PCOS becomes PMOS
In May 2026, polycystic ovary syndrome was renamed polyendocrine metabolic ovarian syndrome (PMOS). The 14-year international process, led from Monash University in Melbourne, concluded that the old name wrongly pointed to ovarian cysts and hid the condition’s effects on hormones and metabolism.
Source: PCOS name change (media release on Teede HJ et al., The Lancet, 2026). Endocrine Society, 2026.
Where the words come from
Some of the ideas in this timeline live on in everyday language. These words still carry the old views of women's bodies that shaped how medicine treated them.
- Hysteria
From the Greek hystera, “womb”. Ancient doctors blamed a range of women’s symptoms on a womb they believed could move around the body. Hysteria was dropped as a diagnosis in 1980, but “hysterical” is still used to dismiss someone as overreacting.
Source: Women and hysteria in the history of mental health (Tasca C et al.). Clinical Practice and Epidemiology in Mental Health, 8, 2012.
- Pudendum
The anatomical name for the external genitals, still used for the pudendal nerve. It comes from the Latin pudere, “to be ashamed”. Medicine’s own vocabulary describes women’s genitals as the part to be ashamed of. Anatomists still debate whether names like this should change.
Source: Changes of anatomical nomenclature must be deliberate: the female external genitalia (Kachlik D). Clinical Anatomy, 34(2), 2021.
- Vagina
Latin for “sheath” or “scabbard”, the holder for a sword. The organ was named for what goes into it rather than for what it does.
Source: Changes of anatomical nomenclature must be deliberate: the female external genitalia (Kachlik D). Clinical Anatomy, 34(2), 2021.
- Menopause
Coined by the French doctor Charles de Gardanne, who first used an early form of the word in 1812 and settled on ménopause in 1821, from the Greek for “month” and “stop”. Something every woman who reaches midlife goes through had no medical name until about two hundred years ago.
Source: La naturalisation de la ménopause : parcours d'une catégorie façonnée par le genre (Charlap C). Émulations: revue de sciences sociales, 15.